CXCR4 and cancer

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Pathology international (Print)

• Publication date

  2010-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1440-1827.2010.02548.xPMID 20594270
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression

  2009cited by this paper
• Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate

  2009cited by this paper
• Prostate cancer stem cells

  2009cited by this paper
• Effects of CXCR4 antagonist CTCE‐9908 on prostate tumor growth

  2009cited by this paper
• CD26/dipeptidyl peptidase IV regulates prostate cancer metastasis by degrading SDF-1/CXCL12

  2008cited by this paper
• Tumor cell-specific blockade of CXCR4/SDF-1 interactions in prostate cancer cells by hTERT promoter induced CXCR4 knockdown: A possible metastasis preventing and minimizing approach

  2008cited by this paper
• Establishment of CXCR4-small interfering RNA retrovirus vector driven by human prostate-specific antigen promoter and its biological effects on prostate cancer in vitro and in vivo

  2008cited by this paper
• New insights into the role of CXCR4 in prostate cancer metastasis

  2008cited by this paper
• Involvement of SDF‐1α/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma

  2008cited by this paper
• Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma.

  2008cited by this paper
• Differential expression of chemokine receptors on uveal melanoma cells and their metastases.

  2008cited by this paper
• Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival.

  2008cited by this paper
• Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens.

  2007cited by this paper
• Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer.

  2007cited by this paper
• Stromal cell-derived factor-1 enhances motility and integrin up-regulation through CXCR4, ERK and NF-κB-dependent pathway in human lung cancer cells

  2007cited by this paper
• Hypoxia enhances CXCR4 expression in human microvascular endothelial cells and human melanoma cells.

  2007cited by this paper
• CXCL12 G801A Polymorphism Is a Risk Factor for Sporadic Prostate Cancer Susceptibility

  2007cited by this paper
• Stromal cell-derived factor-1 enhances motility and integrin up-regulation through CXCR4, ERK and NF-kappaB-dependent pathway in human lung cancer cells.

  2007cited by this paper
• Involvement of E‐cadherin, β‐catenin, Cdc42 and CXCR4 in the progression and prognosis of cutaneous melanoma

  2007cited by this paper
• CXCR4 chemokine receptor engagement modifies integrin dependent adhesion of renal carcinoma cells.

  2007cited by this paper
• Characterization of the CXCR4 Signaling in Pancreatic Cancer Cells

  2007cited by this paper
• PREFERENTIAL EXPRESSION OF CHEMOKINE RECEPTOR CXCR4 BY HIGHLY MALIGNANT HUMAN GLIOMAS AND ITS ASSOCIATION WITH POOR PATIENT SURVIVAL

  2007cited by this paper
• Overexpression of CXCR4 predicts adverse overall and event‐free survival in patients with unmutated FLT3 acute myeloid leukemia with normal karyotype

  2007cited by this paper
• In vitro characterization and inhibition of the CXCR4/CXCL12 chemokine axis in human uveal melanoma cell lines

  2007cited by this paper
• The anti-cancer compound Nordy inhibits CXCR4-mediated production of IL-8 and VEGF by malignant human glioma cells

  2007cited by this paper
• Prognostic implications of the nuclear localization of Y‐box‐binding protein‐1 and CXCR4 expression in ovarian cancer: Their correlation with activated Akt, LRP/MVP and P‐glycoprotein expression

  2007cited by this paper
• Up-regulation of CXC chemokines and their receptors: implications for proinflammatory microenvironments of ovarian carcinomas and endometriosis.

  2007cited by this paper
• Hypoxia enhances CXCR 4 expression in human microvascular endothelial cells and human melanoma cells

  2007cited by this paper
• Association of CXCR 4 and CCR 7 chemokine receptor expression and lymph node metastasis in human cervical cancer

  2007cited by this paper
• Deletion of the COOH-terminal domain of CXC chemokine receptor 4 leads to the down-regulation of cell-to-cell contact, enhanced motility and proliferation in breast carcinoma cells.

  2006cited by this paper
• CXCL12 polymorphism and malignant cell dissemination/tissue infiltration in acute myeloid leukemia

  2006cited by this paper
• The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis

  2006cited by this paper
• Functional CXCR 4-Expressing Microparticles and SDF-1 Correlate with Circulating Acute Myelogenous Leukemia Cells

  2006cited by this paper
• Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma

  2006cited by this paper
• CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment.

  2006cited by this paper
• Chemokines and cancer

  2006cited by this paper
• CXCR4 expression is associated with lymph-node metastasis of oral squamous cell carcinoma.

  2006cited by this paper
• CXCL12/CXCR4 signaling activates Akt‐1 and MMP‐9 expression in prostate cancer cells: The role of bone microenvironment‐associated CXCL12

  2006cited by this paper
• CXCR4 expression is associated with pelvic lymph node metastasis in cervical adenocarcinoma

  2006cited by this paper
• Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis

  2006cited by this paper
• CXCR 4 expression is associated with lymph-node metastasis of oral squamous cell carcinoma

  2006cited by this paper
• CXCR4 chemokine receptor mediates prostate tumor cell adhesion through alpha5 and beta3 integrins.

  2006cited by this paper
• Persistent CXCR4 expression after preoperative chemoradiotherapy predicts early recurrence and poor prognosis in esophageal cancer.

  2006cited by this paper
• Stromal Derived Factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis

  2006cited by this paper
• Involvement of chemokine receptors in organ-specific metastasis.

  2006cited by this paper
• Strong expression of chemokine receptor CXCR4 by pancreatic cancer correlates with advanced disease.

  2006cited by this paper
• Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4

  2006cited by this paper
• Functional CXCR4-expressing microparticles and SDF-1 correlate with circulating acute myelogenous leukemia cells.

  2006cited by this paper
• Regulation of angiogenesis by hypoxia-inducible factor 1.

  2006cited by this paper
• Epithelial-mesenchymal transition induced by the stromal cell-derived factor-1/CXCR4 system in oral squamous cell carcinoma cells.

  2006cited by this paper
• CXCR4 Chemokine Receptor Mediates Prostate Tumor Cell Adhesion through α5 and β3 Integrins

  2006cited by this paper
• Prostate cancer stem cells.

  2006cited by this paper
• Study on CXCR4/SDF-1α axis in lymph node metastasis of cervical squamous cell carcinoma

  2006cited by this paper
• Association of CXCR4 and CCR7 chemokine receptor expression and lymph node metastasis in human cervical cancer.

  2006cited by this paper
• The bisphosphonate YM529 inhibits osteolytic and osteoblastic changes and CXCR-4-induced invasion in prostate cancer.

  2005cited by this paper
• Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene.

  2005cited by this paper
• Subtype‐specific expression and genetic alterations of the chemokinereceptor gene CXCR4 in medulloblastomas

  2005cited by this paper
• Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha.

  2005cited by this paper
• Expression of CXCR 4 Predicts Poor Prognosis in Patients with Malignant Melanoma

  2005cited by this paper
• Expression of CXCR4 Predicts Poor Prognosis in Patients with Malignant Melanoma

  2005cited by this paper
• CXCL-12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation.

  2005cited by this paper
• Silencing of CXCR4 blocks breast cancer metastasis.

  2005cited by this paper
• Trafficking of Normal Stem Cells and Metastasis of Cancer Stem Cells Involve Similar Mechanisms: Pivotal Role of the SDF‐1–CXCR4 Axis

  2005cited by this paper
• Stromal Cell–Derived Factor-1α and CXCR4 Expression in Hemangioblastoma and Clear Cell-Renal Cell Carcinoma: von Hippel-Lindau Loss-of-Function Induces Expression of a Ligand and Its Receptor

  2005cited by this paper
• Supplemental Data Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion

  2005cited by this paper
• Up-regulation of CXCR 4 Expression in PC-3 Cells by Stromal-Derived Factor-1 A ( CXCL 12 ) Increases Endothelial Adhesion and Transendothelial Migration : Role of MEK / ERK Signaling Pathway – Dependent NFK B Activation

  2005cited by this paper
• The Chemokine Receptor CXCR4 is Regulated by DNA Methylation in Pancreatic Cancer

  2005cited by this paper
• Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor.

  2005cited by this paper
• CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells

  2005cited by this paper
• Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer.

  2005cited by this paper
• Epidermal Growth Factor and Hypoxia-induced Expression of CXC Chemokine Receptor 4 on Non-small Cell Lung Cancer Cells Is Regulated by the Phosphatidylinositol 3-Kinase/PTEN/AKT/Mammalian Target of Rapamycin Signaling Pathway and Activation of Hypoxia Inducible Factor-1α*

  2005cited by this paper
• Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation.

  2005cited by this paper
• Clinical significance of CXCR3 and CXCR4 expression in primary melanoma

  2005cited by this paper
• In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment

  2005cited by this paper
• Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells

  2005cited by this paper
• CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo

  2005cited by this paper
• CCR7 and CXCR4 as Novel Biomarkers Predicting Axillary Lymph Node Metastasis in T1 Breast Cancer

  2005cited by this paper
• CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers.

  2005cited by this paper
• The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells.

  2005cited by this paper
• Transcriptional targeting in renal cancer cell lines via the human CXCR4 promoter.

  2004cited by this paper
• Acquisition of lymph node, but not distant metastatic potentials, by the overexpression of CXCR4 in human oral squamous cell carcinoma

  2004cited by this paper
• The SDF-1/CXCL 12/CXCR4 biological axis in non-small cell lung cancer metastases.

  2004cited by this paper
• The clinicopathological significance of the expression of CXCR4 protein in oral squamous cell carcinoma.

  2004cited by this paper
• CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer.

  2004cited by this paper
• A new key in breast cancer metastasis.

  2004cited by this paper
• CXCR4 Activation Induces Epidermal Growth Factor Receptor Transactivation in an Ovarian Cancer Cell Line

  2004cited by this paper
• Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis

  2004cited by this paper
• Adverse drug reactions: A broader perspective

  2004cited by this paper
• CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice.

  2004cited by this paper
• Correlation between CXCR4 and Homing or Engraftment of Acute Myelogenous Leukemia

  2004cited by this paper
• The CXCL12–CXCR4 chemotactic pathway as a target of adjuvant breast cancer therapies

  2004cited by this paper
• CXCR4-mediated adhesion and MMP-9 secretion in head and neck squamous cell carcinoma.

  2004cited by this paper
• The role of adhesion molecules and chemokine receptor CXCR4 (CD184) in small cell lung cancer.

  2004cited by this paper
• Identification of human brain tumour initiating cells

  2004cited by this paper
• Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas.

  2004cited by this paper
• Molecular characterization of the tumor microenvironment in breast cancer.

  2004cited by this paper
• Increased Survival, Proliferation, and Migration in Metastatic Human Pancreatic Tumor Cells Expressing Functional CXCR4

  2004cited by this paper
• Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome.

  2004cited by this paper
• Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas

  2004cited by this paper
• Unique SDF-1-induced activation of human precursor-B ALL cells as a result of altered CXCR4 expression and signaling.

  2004cited by this paper

• The Patterns of P53, E-Cadherin, β-Catenin, CXCR4 and Podoplanin Expression in Oral Squamous Cell Carcinoma Suggests a Hybrid Invasion Model: an Immunohistochemical Study on Tissue Microarrays

  2025cites this paper
• Unveiling the Involvement of Extracellular Vesicles in Breast Cancer’s Organotrophic Metastasis: Molecular Mechanisms and Translational Prospects

  2025cites this paper
• CXCR4 confers stemness and radioresistance in chordoma cells

  2025cites this paper
• Molecular Docking Studies of Scutellaria Baicalensis Targeting HIV Co-Receptor CXCR4.

  2025cites this paper
• CXCR4 Inhibition Induces Tumor Necrosis by Selectively Targeting the Proliferating Blood Vessels in Oral Squamous Cell Carcinoma

  2025cites this paper
• Targeting the CXCR4/CXCL12 Axis in Cancer Therapy: Analysis of Recent Advances in the Development of Potential Anticancer Agents

  2025cites this paper
• Targeting the chemokine receptor CXCR4 for cancer therapies

  2025cites this paper
• Recent advances targeting chemokines for breast cancer.

  2024cites this paper
• GPRASP protein deficiency triggers lymphoproliferative disease by affecting B‐cell differentiation

  2024cites this paper
• Antibody-activation of connexin hemichannels in bone osteocytes with ATP release suppresses breast cancer and osteosarcoma malignancy

  2024cites this paper
• Applying Molecular Modeling to the Design of Innovative, Non-Symmetrical CXCR4 Inhibitors with Potent Anticancer Activity

  2024cites this paper
• Advancing non-small cell lung cancer treatment: the power of combination immunotherapies

  2024cites this paper
• Construction of a prognostic model for autophagy in Wilm's tumor

  2024cites this paper
• Harmonizing hope: navigating the osteoarthritis melody through the CCL2/CCR2 axis for innovative therapeutic avenues

  2024cites this paper
• Bone metastasis in endocrine-related cancer: unravelling invasion and destruction.

  2024cites this paper
• Chemokines as possible therapeutic targets in metastatic melanoma

  2023cites this paper
• Adult-Onset Transcriptomic Effects of Developmental Exposure to Benzene in Zebrafish (Danio rerio): Evaluating a Volatile Organic Compound of Concern

  2023cites this paper
• CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment

  2023cites this paper
• Understanding crosstalk of organ tropism, tumor microenvironment and noncoding RNAs in breast cancer metastasis

  2023cites this paper
• Gene Variations of Chemokine and Chemokine Receptor CXCL12/CXCR4 in Lung Cancer.

  2023cites this paper
• Active constituents of herbal medicines for breast cancer: Current status

  2023cites this paper
• Exploring the Immune Landscape of Cirrhosis through Weighted Gene Co-expression Network Analysis.

  2023cites this paper
• The pathological role of C-X-C chemokine receptor type 4 (CXCR4) in colorectal cancer (CRC) progression; special focus on molecular mechanisms and possible therapeutics.

  2023cites this paper
• Bispecific antibodies revolutionizing breast cancer treatment: a comprehensive overview

  2023cites this paper
• Peptide modulators of cell migration: Overview, applications and future development

  2023cites this paper
• Emerging RNA-Based Therapeutic and Diagnostic Options: Recent Advances and Future Challenges in Genitourinary Cancers

  2023cites this paper
• An osteosarcoma-on-a-chip model for studying osteosarcoma matrix-cell interactions and drug responses

  2023cites this paper
• Benefits of plerixafor for mobilization of peripheral blood stem cells prior to autologous transplantation: a dual-center retrospective cohort study.

  2023cites this paper
• Purinergic signaling: decoding its role in COVID-19 pathogenesis and promising treatment strategies

  2023cites this paper
• The role of lactate metabolism-related LncRNAs in the prognosis, mutation, and tumor microenvironment of papillary thyroid cancer

  2023cites this paper
• Metastatic human hepatoblastoma cells exhibit enhanced tumorigenicity, invasiveness and a stem cell-like phenotype.

  2022cites this paper
• Epigenetic Regulation of CXCR4 Signaling in Cancer Pathogenesis and Progression.

  2022cites this paper
• Potential molecular mechanisms and clinical progress in liver metastasis of breast cancer.

  2022cites this paper
• Kruppel-like factor 2 acts as a tumor suppressor in human retinoblastoma.

  2022cites this paper
• Racial disparities in prostate cancer: A complex interplay between socioeconomic inequities and genomics

  2022cites this paper
• Molecular Characterization of CF33 Canine Cell Line and Evaluation of Its Ability to Respond against Infective Stressors in Sight of Anticancer Approaches

  2022cites this paper
• Bone Metastasis of Breast Cancer: Molecular Mechanisms and Therapeutic Strategies

  2022cites this paper
• [^68Ga]Ga-Pentixafor PET/CT imaging for in vivo CXCR4 receptor mapping in different lung cancer histologic sub-types: correlation with quantitative receptors’ density by immunochemistry techniques

  2022cites this paper
• CXCR4 expression is associated with proneural‐to‐mesenchymal transition in glioblastoma

  2022influential citation
• Biomarkers of disease recurrence in stage I testicular germ cell tumours

  2022cites this paper
• CXCR4 and MMP-9 Immunoexpression are Associated with Metastasis in Infiltrating Urothelial Carcinoma of The Bladder

  2022cites this paper
• The multifaceted roles of peptides in "always-on" near-infrared fluorescent probes for tumor imaging.

  2022cites this paper
• Comparative evaluation of somatostatin and CXCR4 receptor expression in different types of thyroid carcinoma using well-characterised monoclonal antibodies

  2022cites this paper
• The involvement of a chemokine receptor antagonist CTCE‐9908 and kynurenine metabolites in cancer development

  2022cites this paper
• Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention

  2022cites this paper
• Imaging CXCR4 receptors expression for staging multiple myeloma by using 68Ga-Pentixafor PET/CT: Comparison with 18F-FDG PET/CT.

  2022cites this paper
• miRNAs as Biomarkers and Possible Therapeutic Strategies in Synovial Sarcoma

  2022cites this paper
• The Epithelial–Stromal Microenvironment in Early Colonic Neoplasia

  2021cites this paper
• Prognostic significance of SDF-1 chemokine and its receptors CXCR4 and CXCR7 involved in EMT of prostate cancer.

  2021cites this paper
• Innovative Biomaterials for the Treatment of Bone Cancer

  2021cites this paper
• Lidocaine suppressed the movement of A549 cells by the CXCR4 signal

  2021cites this paper
• The Breast Tumor Microenvironment: A Key Player in Metastatic Spread

  2021cites this paper
• MicroRNA-409-3p regulates macrophage migration in polymyositis through targeting CXCR4

  2021cites this paper
• Immune Landscape of Pancreas Ductal Adenocarcinoma: Current Therapeutic Strategies and Future Perspective

  2021cites this paper
• A Panel of Tumor Biomarkers to Predict Complete Pathological Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer

  2021cites this paper
• Hypoxia-induced lncHILAR promotes renal cancer cell invasion and metastasis via ceRNA for the miR-613/206/1-1-3p/Jagged-1/Notch/CXCR4 signaling pathway.

  2021cites this paper
• MTSS1 inhibits colorectal cancer metastasis by regulating the CXCR4/CXCL12 signaling axis

  2021cites this paper
• The effect of gemcitabine combined with AMD3100 applying to cholangiocarcinoma RBE cell lines to CXCR4/CXCL12 axis

  2021cites this paper
• Prognosis and Genomic Landscape of Liver Metastasis in Patients With Breast Cancer

  2021cites this paper
• Der Chemokinrezeptor CXCR4 – seine Entwicklung und Bedeutung in der nuklearmedizinischen Theranostik

  2021cites this paper
• Association of CXCR4 mRNA Expression with Clinicopathological Aspects of Invasive Breast Carcinoma

  2021cites this paper
• Lidocaine inhibited migration of NSCLCA549 cells via the CXCR4 regulation

  2021cites this paper
• Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer

  2021cites this paper
• Design, synthesis, and evaluation of novel CXCR4 antagonists based on an aminoquinoline template.

  2020cites this paper
• Safety and Pharmacokinetics of CXCR4 Peptide Antagonist, LY2510924, in Combination with Durvalumab in Advanced Refractory Solid Tumors

  2020cites this paper
• Small Molecular Immune Modulators as Anticancer Agents.

  2020cites this paper
• Regulation of Cancer Immune Checkpoints: Molecular and Cellular Mechanisms and Therapy

  2020cites this paper
• Angiocrine endothelium: from physiology to cancer

  2020cites this paper
• GRK2 Enforces Androgen Receptor-Dependence in the Prostate and Prostate Tumors

  2020cites this paper
• Targeting G protein-coupled receptors in cancer therapy.

  2020cites this paper
• A novel GPCR target in correlation with androgen deprivation therapy for prostate cancer drug discovery

  2020cites this paper
• CXC Chemokine Receptors in the Tumor Microenvironment and an Update of Antagonist Development.

  2020cites this paper
• Tumor inhibition or tumor promotion? The duplicity of CXCR3 in cancer

  2020cites this paper
• CXCR4 Antagonist AMD3100 Reverses the Resistance to Tamoxifen in Breast Cancer via Inhibiting AKT Phosphorylation

  2020cites this paper
• Chemokine receptor CXCR4 oligomerization is disrupted selectively by the antagonist ligand IT1t

  2020cites this paper
• NIMBus: a negative binomial regression based Integrative Method for mutation Burden Analysis

  2020cites this paper
• PTEN inactivation induces epithelial-mesenchymal transition and metastasis by intranuclear translocation of β-catenin and snail/slug in non-small cell lung carcinoma cells.

  2019cites this paper
• Somatostatin and chemokine CXCR4 receptor expression in pancreatic adenocarcinoma relative to pancreatic neuroendocrine tumours

  2019cites this paper
• Carrier-Free CXCR4-Targeted Nanoplexes Designed for Polarizing Macrophages to Suppress Tumor Growth

  2019cites this paper
• Involvement of CXCR4 in Normal and Abnormal Development

  2019cites this paper
• The role of CXCR4 in multiple myeloma: Cells’ journey from bone marrow to beyond

  2019cites this paper
• Microsomal prostaglandin E synthase-1 promotes lung metastasis via SDF-1/CXCR4-mediated recruitment of CD11b+Gr1+MDSCs from bone marrow.

  2019cites this paper
• Amide-sulfamide modulators as effective anti-tumor metastatic agents targeting CXCR4/CXCL12 axis.

  2019cites this paper
• Molecular Mechanisms of Breast Cancer Metastasis to the Lung: Clinical and Experimental Perspectives

  2019cites this paper
• AWARD NUMBER: W81XWH-17-1-0470 TITLE: Targeted Lung-Derived Proteins as a Therapeutic Strategy Against Breast Cancer Metastasis

  2019cites this paper
• Recent Advances of Small Molecular Regulators Targeting G Protein-Coupled Receptors Family for Oncology Immunotherapy.

  2019cites this paper
• Radionuclide-Labeled Peptides for Imaging and Treatment of CXCR4- Overexpressing Malignant Tumors.

  2019cites this paper
• MiR-9 functions as a tumor suppressor in acute myeloid leukemia by targeting CX chemokine receptor 4.

  2019cites this paper
• LncRNA UCA1 acts as a sponge of miR-204 to up-regulate CXCR4 expression and promote prostate cancer progression

  2019cites this paper
• Different somatostatin and CXCR4 chemokine receptor expression in gastroenteropancreatic neuroendocrine neoplasms depending on their origin

  2019cites this paper
• Clinicopathological significance and prognostic role of chemokine receptor CXCR4 expression in pancreatic ductal adenocarcinoma, a meta-analysis and literature review.

  2019cites this paper
• A self-assembled RNA-triple helix hydrogel drug delivery system targeting triple-negative breast cancer.

  2019cites this paper
• Molecular characterization and expression analysis of Asian swamp eel (Monopterus albus) CXC chemokine receptor (CXCR) 1a, CXCR1b, CXCR2, CXCR3a, CXCR3b, and CXCR4 after bacteria and poly I:C challenge.

  2019cites this paper
• Silibinin efficacy in a rat model of pulmonary arterial hypertension using monocrotaline and chronic hypoxia

  2019cites this paper
• Discovery of N-Alkyl Piperazine Side Chain Based CXCR4 Antagonists with Improved Drug-like Properties.

  2018cites this paper
• Chapter 8 – Role of Gambogic Acid in Chemosensitization of Cancer

  2018cites this paper
• Role of immune system in tumor progression and carcinogenesis

  2018cites this paper
• MicroRNA‐381‐induced down‐regulation of CXCR4 promotes the proliferation of renal tubular epithelial cells in rat models of renal ischemia reperfusion injury

  2018cites this paper
• New therapeutic approaches in sarcoma: Immunomodulation and tumor microenvironment

  2018cites this paper
• Untersuchung der Expression des Chemokinrezeptors CXCR4 in chemisch induzierten Bronchialkarzinomen in Mäusen

  2018influential citation